Illness of immune reconstitution: Recognition and management

被引：8
作者：
Gardner E.M. [1 ]
Connick E. [1 ]
机构：
[1] Division of Infectious Diseases, University of Colorado, Health Sciences Center, Denver, CO 80262
来源：
Current Infectious Disease Reports | 2004年 / 6卷 / 6期
关键词：
Progressive Multifocal Leukoencephalopathy; Immune Reconstitution; Progressive Multifocal Leukoencephalopathy; Mycobacterium Avium Complex; Cytomegalovirus Retinitis;
D O I：
10.1007/s11908-004-0068-4
中图分类号：
学科分类号：
摘要：
Some individuals who initiate highly active antiretroviral therapy (HAART) develop new or worsening opportunistic infections or malignancies despite improvements in surrogate markers of HIV-I infection. These events of paradoxical clinical worsening, also known as immune reconstitution syndromes (IRS), are increased in individuals with prior opportunistic infections or low CD4+ T-cell nadirs. They are thought to result from reconstitution of the immune system's ability to recognize pathogens or tumor antigens that were previously present, but clinically asymptomatic. There is no consensus regarding the diagnostic presentation and treatment is largley based on case reports. With the introduction of HAART into resource-limited settings, it is likely that significantly more and distinct forms of IRS will be observed. Prospective studies of the incidence and treatment of IRS in multiple settings are critical to better understand their pathogenesis and optimal management. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：483 / 493
页数：10
相关论文
共 140 条
[1]  
Palella Jr. F.J., Delaney K.M., Moorman A.C., Et al., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, N. Engl. J. Med., 338, pp. 853-860, (1998)
[2]  
Hirsch H.H., Kaufmann G., Sendi P., Battegay M., Immune reconstitution in HIV-infected patients, Clin. Infect. Dis., 38, pp. 1159-1166, (2004)
[3]  
French M.A., Lenzo N., John M., Et al., Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy, HIV Med., 1, pp. 107-115, (2000)
[4]  
Shelburne III S.A., Hamill R.J., Rodriguez-Barradas M.C., Et al., Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy, Medicine (Baltimore), 81, pp. 213-227, (2002)
[5]  
Cheng V.C., Yuen K.Y., Chan W.M., Et al., Immunorestitution disease involving the innate and adaptive response, Clin. Infect. Dis., 30, pp. 882-892, (2000)
[6]  
French M.A., Mallal S.A., Dawkins R.E., Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients, AIDS, 6, pp. 1293-1297, (1992)
[7]  
French M.A., Price P., Stone S.F., Immune restoration disease after antiretroviral therapy, AIDS, 18, pp. 1615-1627, (2004)
[8]  
Cooney E.L., Clinical indicators of immune restoration following highly active antiretroviral therapy, Clin. Infect. Dis., 34, pp. 224-233, (2002)
[9]  
Shelburne III S.A., Hamill R.J., The immune reconstitution inflammatory syndrome, AIDS Rev., 5, pp. 67-79, (2003)
[10]  
DeSimone J.A., Pomerantz R.J., Babinchak T.J., Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy, Ann. Intern. Med., 133, pp. 447-454, (2000)
12345678910